Financing led by Genesys Capital with participation from Cleveland Clinic and JobsOhio Ventures -- Genesys Capital Managing Partner Jamie Stiff to join Enspire Board of Directors -- Proceeds to ...

For more than twenty years deep brain stimulation (DBS) is being used in patients with movement disorders, predominantly in refractory Parkinson's disease (PD) followed by dystonia and essential ...

Researchers at EPFL and Lausanne University Hospital (CHUV), led by professors Grégoire Courtine and Jocelyne Bloch, have achieved a major milestone in the treatment of spinal cord injuries (SCI). By ...

Medtronic Percept™ DBS therapy is the only sensing-enabled † DBS system available, allowing a physician to use data from a patient’s brain activity to personalize their treatment. Andy says Medtronic ...

Please provide your email address to receive an email when new articles are posted on . Offering asleep or awake DBS aims to provide PD patients choice, impetus for choosing DBS therapy sooner.

Nat Clin Pract Neurol. 2008;4(8):424-426. Several factors limit the capacity of the clinical results to date to rule out DBS as a neuroprotective therapy. First, continued functional decline does not ...

CLEVELAND, Jan. 13, 2026 /PRNewswire/ -- Enspire DBS Therapy, Inc. ("Enspire"), a clinical-stage company developing an implantable neuromodulation therapy for post-stroke recovery, today announced ...